Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy

MH Baig, M Adil, R Khan, S Dhadi, K Ahmad… - Seminars in cancer …, 2019 - Elsevier
Extensive growth of cancer in humans is a major cause of death. Numerous studies are
being conducted to improve the early diagnosis, prevention, and treatment of cancer. Recent …

Gamma delta T cell therapy for cancer: it is good to be local

CD Pauza, ML Liou, T Lahusen, L Xiao… - Frontiers in …, 2018 - frontiersin.org
Human gamma delta T cells have extraordinary properties including the capacity for tumor
cell killing. The major gamma delta T cell subset in human beings is designated Vγ9Vδ2 and …

Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their …

A Rai, DW Greening, M Chen, R Xu, H Ji… - …, 2019 - Wiley Online Library
Cancer‐associated fibroblasts (CAFs) are a heterogeneous population of activated
fibroblasts that constitute a dominant cellular component of the tumor microenvironment …

Novel prospects of statins as therapeutic agents in cancer

S Pisanti, P Picardi, E Ciaglia, A D'Alessandro… - Pharmacological …, 2014 - Elsevier
Statins are well known competitive inhibitors of hydroxymethylglutaryl-CoA reductase
enzyme (HMG-CoA reductase), thus traditionally used as cholesterol-lowering agents. In …

Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development

MK Dhar, A Koul, S Kaul - New biotechnology, 2013 - Elsevier
As isoprenoid biosynthetic pathway has gained importance since last few years, key
enzymes of this pathway have been characterized and their functional roles in the cell …

[HTML][HTML] Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells

H Karlic, R Thaler, C Gerner, T Grunt, K Proestling… - Cancer genetics, 2015 - Elsevier
The mevalonate pathway provides metabolites for post-translational modifications such as
farnesylation, which are critical for the activity of RAS downstream signaling. Subsequently …

The potential to treat lung cancer via inhalation of repurposed drugs

WH Lee, CY Loo, M Ghadiri, CR Leong… - Advanced drug delivery …, 2018 - Elsevier
Lung cancer is a highly invasive and prevalent disease with ineffective first-line treatment
and remains the leading cause of cancer death in men and women. Despite the …

Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers

DD Waller, J Park, YS Tsantrizos - Critical reviews in biochemistry …, 2019 - Taylor & Francis
Dysregulation of isoprenoid biosynthesis is implicated in numerous biochemical disorders
that play a role in the onset and/or progression of age-related diseases, such as …

Phosphonate and bisphosphonate inhibitors of farnesyl pyrophosphate synthases: A structure-guided perspective

J Park, VR Pandya, SJ Ezekiel, AM Berghuis - Frontiers in Chemistry, 2021 - frontiersin.org
Phosphonates and bisphosphonates have proven their pharmacological utility as inhibitors
of enzymes that metabolize phosphate and pyrophosphate substrates. The blockbuster …

Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling

P Seshacharyulu, S Halder, R Nimmakayala… - …, 2022 - thelancet.com
Background Radiation therapy (RT) has a suboptimal effect in patients with pancreatic
ductal adenocarcinoma (PDAC) due to intrinsic and acquired radioresistance (RR) …